Gut microbiota are known to produce an intermediate metabolite in the production of trimethylamine N-oxide that promotes atherosclerosis. Now, another metabolite produced by the same bacteria has been identified that prevents atherosclerosis. The basis for these opposing microbial effects are dictated by diet.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Mechanism of sodium butyrate, a metabolite of gut microbiota, regulating cardiac fibroblast transdifferentiation via the NLRP3/Caspase-1 pyroptosis pathway
Journal of Cardiothoracic Surgery Open Access 15 April 2024
-
Fecal level of butyric acid, a microbiome-derived metabolite, is increased in patients with severe carotid atherosclerosis
Scientific Reports Open Access 26 December 2022
-
Distinguishing feature of gut microbiota in Tibetan highland coronary artery disease patients and its link with diet
Scientific Reports Open Access 16 September 2021
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Change history
03 January 2019
In the version of this News & Views originally published, owing to production error, the concentration scales given for butyrate circulates in the bloodstream and colon were incorrect. It was stated that “butyrate circulates at mM levels (as opposed to µM in colon)”; this should have read “butyrate circulates at µM levels (as opposed to mM in colon)”. This error has now been corrected.
References
Wikoff, W. R. Proc. Natl Acad. Sci. USA 106, 3698–3703 (2009).
Kasahara, K. et al. Nat. Microbiol. https://doi.org/10.1038/s41564-018-0272-x (2018).
Smith, P. M. et al. Science 341, 569–573 (2013).
Furusawa, Y. et al. Nature 504, 446–450 (2013).
Kelly, C. J. et al. Cell Host Microbe 13, 662–671 (2015).
Bordin, M., D’Atri, F., Guillemot, L. & Citi, S. Mol. Cancer Res. 2, 692–701 (2004).
Hatayama, H., Washita, J., Kuwajima, A. & Abe, T. Biochem. Biophys. Res. Commun. 356, 599–603 (2007).
Chang, P. V., Hao, L., Offermanns, S. & Medzhitov, R. Proc. Natl Acad. Sci. USA 111, 2247–2252 (2013).
Bazzano, L. A. et al. Arch. Intern. Med. 163, 1897–1904 (2003).
Sonnenburg, E. D. et al. Nature 529, 212–215 (2016).
Sampson, T. R. et al. Cell 167, 1469–1480 (2016).
Rath, S., Heidrich, B., Pieper, D. H. & Vital, M. Microbiome 5, 54 (2017).
Wang, Z. et al. Nature 472, 57–63 (2011).
Koeth, R. A. et al. Nat. Med. 19, 576–585 (2013).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing interests.
Rights and permissions
About this article
Cite this article
Bultman, S.J. Bacterial butyrate prevents atherosclerosis. Nat Microbiol 3, 1332–1333 (2018). https://doi.org/10.1038/s41564-018-0299-z
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41564-018-0299-z
This article is cited by
-
Mechanism of sodium butyrate, a metabolite of gut microbiota, regulating cardiac fibroblast transdifferentiation via the NLRP3/Caspase-1 pyroptosis pathway
Journal of Cardiothoracic Surgery (2024)
-
Fecal level of butyric acid, a microbiome-derived metabolite, is increased in patients with severe carotid atherosclerosis
Scientific Reports (2022)
-
Distinguishing feature of gut microbiota in Tibetan highland coronary artery disease patients and its link with diet
Scientific Reports (2021)
-
Conversion of dietary inositol into propionate and acetate by commensal Anaerostipes associates with host health
Nature Communications (2021)
-
Butyrate producing colonic Clostridiales metabolise human milk oligosaccharides and cross feed on mucin via conserved pathways
Nature Communications (2020)
